The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients

Montazerifar, Farzaneh; Bolouri, Ahmad; Mozaffar, Milad Mahmoudi; Karajibani, Mansour

doi:10.14740/cr507w

Cited by 39 publications

(48 citation statements)

References 30 publications

(62 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The clearly higher prevalence of MetS in females than in males was supposed to result from the lower metabolic rate with increased body fat percentage in postmenopausal women. The prevalence of MetS from 14.2% in 2012 to 24.4% in 2015 showed a climbing trend similar between male and female, which conformed with the findings of Ranasinghe et al(2017), Montazerifar et al (2016) and Franca et al (2016). The incidence of MetS calculated from the present study (14.1% -22.2%, average: 17.6%) was much lower than the value of 30% as suggested by Van et al (2018).…”

Section: Discussionsupporting

confidence: 88%

“…Compared with non-MetS patients, MetS patients run1 to 4 times higher risks of cardiovascular disease and diabetes. Diabetic patients with MetS make 4.9 times higher incidence of cardiovascular disease than those without MetS (Montazerifar, Bolouri, Mahmoudi Mozaffar, & Karajibani, 2016). Patients with MetS also have higher risk of colorectal cancer, breast cancer, pancreatic cancer, prostate cancer, and gastric cancer (Hu et al, 2017;Uzunlulu, Telci Caklili, & Oguz, 2016).…”

Section: Introductionmentioning

confidence: 99%

“…38.2% in female) (Abbasi-Ghahramanloo, Soltani, Gholami, Erfani, & Yosaee, 2016). In Iran, the adult prevalence of MetS was 49.5% (40.2% in male vs. 55.9% in female) (Montazerifar et al, 2016). In the US, the prevalence was higher than 25% (Abbasi-Ghahramanloo, Soltani, Gholami, Erfani, & Yosaee, 2016), while in Amsterdam, the prevalence and incidence of community residents aged 55 to 85 years were 37% and 30%, respectively (Van Ancum et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

“…MetS is defined as at least three of the following metabolic risk factors to be diagnosed with: waist circumference (≥ cm for males, ≥ 80 cm for females), blood pressure (systolic ≥ 130 mmHg or diastolic ≥ 85 mmHg), fasting blood glucose ≥ 100 mg/dL, HDL-C (< 40 mg/dL for males, < 50 mg/dL for females), and triglyceride >150 mg/dL (Montazerifar et al, 2016). Other compound factors are old age, higher BMI, living with family members, lower level of education, lack of physical exercise, female, obesity, and family history (Franca, Lima, & Vieira, 2016;Lin et al, 2015;Montazerifar et al, 2016;Roos et al, 2017). Predictors of MetS in community older adults include heart disease, peripheral artery disease, diabetes, cerebral stroke and higher BMI (Van Ancum et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Factor Analysis of Metabolic Syndrome in Aged Population Undergoing Periodical Health Examinations

Chiu

2020

IJSN

View full text Add to dashboard Cite

Background: Metabolic syndrome (MetS) is a common health problem in aged people. The cluster of diseases associated with MetS, namely, heart disease, cerebrovascular disease, diabetes, hypertensive disease and renal disease, had made a death rate of 0.17%, higher than 0.15% attributed to cancers.Aims: To investigate the prevalence, incidence and reversion rate of MetS in Aged population undergoing periodical health examinations, as well as the associated impact factors. Results:The prevalence of MetS was found to be 19.9% among all the subjects studied, to be higher in female (23.1%) than in male (18.3%). The incidence of MetS was 17.6%. In contrast, the reversion rate of MetS was 45.0%. Sex (p = 0.045) and history of hyperlipidemia (p = 0.006) were two factors found to be significantly associated with the reversion rate of MetS. Conclusion:Physical examinations may help early detect diseases and revise high risk factors timely. Compared with the ordinary older population, those undergoing periodical health examinations tended to have lower incidence of MetS, better health status and higher disease reversion rate than incidence. To sum up, individualized health education and guidance is an imperative and critical nursing intervention to ensure a healthy state for aged population.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Factor Analysis of Metabolic Syndrome in Aged Population Undergoing Periodical Health Examinations

Chiu

2020

IJSN

View full text Add to dashboard Cite

show abstract

“…12 A study in Iran shows 49.5. 13 A report of US population showed about 44% of MetS prevalence in adults.…”

Section: Discussionmentioning

confidence: 99%

Metabolic Syndrome

Anwer¹,

Kaleem²,

Abbas³

et al. 2018

TPMJ

View full text Add to dashboard Cite

ABSTRACT… Objectives: The objective of this study was to investigate the importance of individual IHD risk factors and major components of the metabolic syndrome associated with IHD. Study Design: Descriptive cross sectional study. Setting: Cardiology Department of Gulab Devi Chest Hospital Lahore. Period: Nov, 2015 to Feb, 2016. Methodology: Patients of either gender and from 20 to 90 year of age admitted with IHD via emergency department were recruited after informed consent. The frequency of metabolic syndrome was evaluated in these patients. In addition the individual component of metabolic syndrome as risk factor of IHD was calculated. The data was analysed by using the SPSS version.16. Results: The metabolic syndrome present in 44.67%of IHD patients and more prevalent in men 52% than in women 48%. Total of 150 patients of IHD studied with both gender as male 94(63.33%) vs female 55 (36.67%). The most common risk factor of metabolic syndrome for IHD was high blood pressure present in 75% of patients followed by diabetes in 50%, abdominal obesity 40.67%, low HDL 42.67% and high TG in 32%. Conclusion: The metabolic syndrome is highly prevalent among IHD patients especially in men. The most common risk factors are hypertension and diabetes.

show abstract

Phytonutrient supplements and metabolic biomarkers of cardiovascular disease: An umbrella review of meta‐analyses of clinical trials

Hoang

Kim

2021

Phytotherapy Research

View full text Add to dashboard Cite

Phytonutrients exert several pharmacological effects on humans. In this study, we performed an umbrella review of the association of phytonutrient supplements (PNSs) with biomarkers of cardiovascular disease. Relevant published systematic reviews and meta‐analyses of clinical trials were identified by searching PubMed, Embase, and Cochrane Library until July 4, 2020. Weighted mean differences (WMDs) and 95% confidence intervals (CIs) for summarized effects and I2 statistics of heterogeneity were extracted from individual studies or reanalyzed using a random‐effects model. Of the 50 included studies, pooled effects of PNSs on blood pressure, lipid profiles, and glycemic control were reported in 16, 25, and 14 articles, respectively. The findings appeared to be highly heterogeneous among individual trials of included systematic reviews and meta‐analyses. Ginger (WMD = −6.36 mmHg, 95% CI = −11.27, −1.46) and Hibiscus sabdariffa (WMD = −7.58 mmHg, 95% CI = −9.69, −5.46) were associated with lowered systolic blood pressure, whereas Aloe vera, Nigella sativa, and spirulina were associated with beneficial effects on both lipid profiles and glycemic control. In summary, this umbrella review has provided up‐to‐date evidence for the effect of PNSs on biomarkers related to hypertension, dyslipidemia, and diabetes. The results must be interpreted with caution due to potential heterogeneity.

show abstract

The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients

Cited by 39 publications

References 30 publications

Factor Analysis of Metabolic Syndrome in Aged Population Undergoing Periodical Health Examinations

Factor Analysis of Metabolic Syndrome in Aged Population Undergoing Periodical Health Examinations

Metabolic Syndrome

Phytonutrient supplements and metabolic biomarkers of cardiovascular disease: An umbrella review of meta‐analyses of clinical trials

Contact Info

Product

Resources

About